Amedisys Inc
NASDAQ:AMED

  • LAST PRICE
    91.0500
  • TODAY'S CHANGE (%)
    -0.1100 (-0.1207%)
  • Bid / Lots
    66.0000/ 1
  • Ask / Lots
    96.0000/ 5
  • Open / Previous Close
    90.9800 / 91.1600
  • Day Range
    90.8000
    91.1500
  • 52 Week Range
    73.1000
    96.4360
  • Volume
    81,673

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

  • Today

      Show headlines and story abstract

    • 6 hours ago by MT Newswires
      Companies Mentioned: AMED
      04:47 PM EDT, 04/24/2024 (MT Newswires) -- ...

    • 6 hours ago by GlobeNewswire
      Companies Mentioned: AMED

    • 7 hours ago by Dow Jones
      Companies Mentioned: AMED
      Inc. is defined as net income attributable to Amedisys, Inc. calculated in accordance with GAAP excluding certain items as described in footnote 1. (4) Adjusted net income attributable to Amedisys, Inc. common stockholders per diluted share is defined as diluted income per share calculated in accordance with GAAP excluding the earnings per share effect of certain items as described in footnote 1. (5) Adjusted EBITDA, adjusted net income attributable to Amedisys, Inc. and adjusted net income attributable to Amedisys, Inc. common stockholders per diluted share should not be considered as an alternative to, or more meaningful than, income before income taxes or other measures calculated in accordance with GAAP. These calculations may not be comparable to a similarly titled measure reported by other companies, since not all companies calculate these non-GAAP financial measures in the same manner.

    • 7 hours ago by Dow Jones
      Companies Mentioned: AMED
      Inc. is defined as net income attributable to Amedisys, Inc. calculated in accordance with GAAP excluding certain items as described in footnote 1. (4) Adjusted net income attributable to Amedisys, Inc. common stockholders per diluted share is defined as diluted income per share calculated in accordance with GAAP excluding the earnings per share effect of certain items as described in footnote 1. (5) Adjusted EBITDA, adjusted net income attributable to Amedisys, Inc. and adjusted net income attributable to Amedisys, Inc. common stockholders per diluted share should not be considered as an alternative to, or more meaningful than, income before income taxes or other measures calculated in accordance with GAAP. These calculations may not be comparable to a similarly titled measure reported by other companies, since not all companies calculate these non-GAAP financial measures in the same manner.

  • Mar 26, 2024

Peers Headlines